Related Experiment Video
Updated: Jul 29, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
17.0K
New-Onset Diabetes in Children during COVID-19: Clinical Case Report
M Aabdi1, A Aarab2, O Es-Saad1
1Anesthesiology and Intensive Care Unit Department, MOHAMMED VI University Hospital Center, Oujda, Morocco.
Case Reports in Endocrinology
|February 25, 2021
Summary
COVID-19 can present atypically in children, sometimes revealing itself through new-onset diabetes and diabetic ketoacidosis. Early suspicion in pediatric cases with hyperglycemia is crucial for timely management.
Area of Science:
- Pediatrics
- Infectious Diseases
- Endocrinology
Background:
- Limited data exists on COVID-19 manifestations in pediatric populations.
- Nonspecific symptoms can delay diagnosis and lead to severe complications.
Observation:
- A 3-year-old child presented with loss of consciousness, lethargy, and stupor, without fever.
- Clinical assessment revealed dehydration, tachypnea, and altered consciousness (Glasgow Coma Scale 10/15).
- Laboratory tests showed hyperglycemia (5 g/L), lymphopenia, glycosuria, ketonuria, and elevated HbA1c (10%).
Findings:
- The child tested positive for COVID-19 via RT-PCR.
- The presentation mimicked new-onset diabetes with diabetic ketoacidosis.
Implications:
- COVID-19 should be considered in children presenting with atypical symptoms like new-onset diabetes and diabetic ketoacidosis.
- Prompt recognition of hyperglycemia and elevated HbA1c in conjunction with COVID-19 suspicion can facilitate early patient management.
More Related Videos
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...